Skip to main content
Premium Trial:

Request an Annual Quote

That's One Fancy Piece of Paper

The Guardian reports on Harvard's George Whitesides and his advances in making microfluidic paper that may be used as diagnostics that will "revolutionise third-world medical testing," the article says. The paper includes polymer-lined channels that direct minute volumes of blood to reagent-filled wells. Whitesides is quoted as saying, "I think it's going to be possible to do sophisticated biological chemistry and cell biology using these methods." The story notes that Whitesides is a co-founder of Diagnostics for All, a nonprofit group that "plans to deploy paper-based liver-function tests in Africa."

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.